SCHEMBL2824397

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3628807	0.87	TP53 (0.45)	SLC16A3SLC16A1MCTS1SMN1; SMN2POLB
	SCHEMBL3630923	0.83	SLC16A3 (0.42)	SLC16A3SLC16A1MCTS1SMN1; SMN2POLB
	SCHEMBL2827801	0.82	MEN1 (0.52)	SLC16A3SLC16A1MCTS1SMN1; SMN2POLB
	SCHEMBL2824961	0.78	FFAR1 (0.50)	TP53MDM2
	SCHEMBL2827000	0.78	FFAR1 (0.51)	TP53MDM2
	SCHEMBL2828508	0.77	FFAR1 (0.49)	TP53MDM2
	SCHEMBL2827647	0.77	FFAR1 (0.51)	TP53MDM2
	SCHEMBL3631457	0.76	SMN1; SMN2 (0.56)	SLC16A3SMN1; SMN2POLBFYNMAPT
	SCHEMBL3624529	0.76	TP53 (0.43)	SLC16A3SLC16A1TP53MDM2
	SCHEMBL3627556	0.76	FFAR1 (0.51)	TP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.